Read + Share
Yiming R, Takeuchi Y, Nishimura T, Li M, et al. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor
osimertinib in lung adenocarcinoma. Cancer Sci 2021;112:3810-3821.
PMID: 34145929
|
 |
|
Yiming R, Takeuchi Y, Nishimura T, Li M, et al. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor
osimertinib in lung adenocarcinoma. Cancer Sci 2021;112:3810-3821.
PMID: 34145929
|
|
|
|